Am. J. Respir. Crit. Care Med., Volume 158, Number 5, November 1998, 1528-1535

Clearance of Clara Cell Secretory Protein 16 (CC16) and Surfactant Proteins A and B from Blood in Acute Respiratory Failure

IAN R. DOYLE, CEDRIC HERMANS, ALFRED BERNARD, TERENCE E. NICHOLAS, and ANDREW D. BERSTEN

Departments of Human Physiology and Critical Care Medicine, School of Medicine, Flinders Medical Centre, Adelaide, Australia; and Industrial Toxicology and Occupational Medicine Unit, Medical School, Catholic University Louvain, Brussels, Belgium

Surfactant proteins A and B (SP-A and SP-B) enter the circulation in a manner that acutely reflects changes in pulmonary function in patients with acute respiratory failure (ARF). There is a small but significant gradient in SP-A and SP-B from arterial to mixed venous (A-V) blood, and since we have detected both proteins in urine, the kidney may be a major site of their systemic clearance. Clara cell secretory protein 16 (CC16), which leaks from the respiratory tract, is known to be freely eliminated by the kidney. Lung plasma protein levels will depend on the rates of both protein entry into and clearance from plasma. In order to study the limiting variable determining these levels, we compared plasma CC16, SP-A, and SP-B in matching A-V blood samples from 37 ARF patients with indices of lung dysfunction and glomerular filtration rate (GFR) (of plasma cystatin C and creatinine). Cystatin C, CC16, SP-A, and SP-B were reduced in mixed venous plasma (all p < 0.001) and their A-V gradients were directly related to their arterial levels (all p < 0.03). Whereas CC16, SP-A, and SP-B reflected blood oxygenation (all p < 0.05), only SP-A and SP-B were related to lung injury score (LIS) (both p < 0.05). In contrast, whereas the clearances of both CC16 and cystatin C were related to that of creatinine (p < 0.02 for both), the clearances of SP-A and SP-B were not. Our study confirms that all three lung proteins are acutely cleared from the circulation of patients with ARF (half-lives < 18 min), and we conclude that whereas the plasma concentration of CC16 depends on GFR, plasma concentrations of SP-A and SP-B reflect lung function independently of this variable.

This article has been cited by other articles:

				J. A. Kropski, R. D. Fremont, C. S. Calfee, and L. B. Ware Clara Cell Protein (CC16), a Marker of Lung Epithelial Injury, Is Decreased in Plasma and Pulmonary Edema Fluid From Patients With Acute Lung Injury Chest, June 1, 2009; 135(6): 1440 - 1447. [Abstract] [Full Text] [PDF]

				A. Mutti, M. Corradi, M. Goldoni, M. V. Vettori, A. Bernard, and P. Apostoli Exhaled Metallic Elements and Serum Pneumoproteins in Asymptomatic Smokers and Patients With COPD or Asthma Chest, May 1, 2006; 129(5): 1288 - 1297. [Abstract] [Full Text] [PDF]

				S. Yoshikawa, T. Miyahara, S. D. Reynolds, B. R. Stripp, M. Anghelescu, F. G. Eyal, and J. C. Parker Clara cell secretory protein and phospholipase A2 activity modulate acute ventilator-induced lung injury in mice J Appl Physiol, April 1, 2005; 98(4): 1264 - 1271. [Abstract] [Full Text] [PDF]

				S. Yoshikawa, J. A. King, S. D. Reynolds, B. R. Stripp, and J. C. Parker Time and pressure dependence of transvascular Clara cell protein, albumin, and IgG transport during ventilator-induced lung injury in mice Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L604 - L612. [Abstract] [Full Text] [PDF]

				J. C. Parker and M. I. Townsley Evaluation of lung injury in rats and mice Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L231 - L246. [Abstract] [Full Text] [PDF]

				C. G. De Pasquale, A. D. Bersten, I. R. Doyle, P. E. Aylward, and L. F. Arnolda Infarct-induced chronic heart failure increases bidirectional protein movement across the alveolocapillary barrier Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2136 - H2145. [Abstract] [Full Text] [PDF]

				O. Lesur, C. Hermans, J.-F. Chalifour, J. Picotte, B. Levy, A. Bernard, and D. Lane Mechanical ventilation-induced pneumoprotein CC-16 vascular transfer in rats: effect of KGF pretreatment Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L410 - L419. [Abstract] [Full Text] [PDF]

				M. Robin, P. Dong, C. Hermans, A. Bernard, A.D. Bersten, and I.R. Doyle Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects Eur. Respir. J., November 1, 2002; 20(5): 1152 - 1161. [Abstract] [Full Text] [PDF]

				C. Hermans, M. Petrek, V. Kolek, B. Weynand, T. Pieters, M. Lambert, and A. Bernard Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis Eur. Respir. J., September 1, 2001; 18(3): 507 - 514. [Abstract] [Full Text] [PDF]

				A. D. BERSTEN, T. HUNT, T. E. NICHOLAS, and I. R. DOYLE Elevated Plasma Surfactant Protein-B Predicts Development of Acute Respiratory Distress Syndrome in Patients with Acute Respiratory Failure Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 648 - 652. [Abstract] [Full Text] [PDF]